Moreover, DNAJB4 overexpression can inhibit the proliferation, tumorigenesis, cell mortality, and invasion of lung cancer cells by reducing cyclin D1 expression, increasing STAT1 and p21WAF1 expression, and then activating the STAT1 pathway [76]. The gene discussed is DNAJB4; the disease is lung cancer.